VYNE Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

November, 18 2021

BRIDGEWATER, N.J., Nov. 18, 2021 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that David Domzalski, Chief Executive Officer, will present at the upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference. The presentation will take the form of a pre-recorded fireside chat, which will be available on the Company’s website beginning November 22nd. Management will also be available for 1-on-1 meetings with investors during the conference November 29th – December 2nd. Presentation details     Date: Monday, November 22, 2021     Time: Beginning at 10:00 a.m. Eastern Time     Presentation Type: Pre-Recorded…

Read More

VYNE Therapeutics to Report Third Quarter 2021 Financial Results on November 10, 2021

October, 28 2021

BRIDGEWATER, N.J., Oct. 28, 2021 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that it will report its financial results for the third quarter ended September 30, 2021, on Wednesday, November 10, 2021, before the market opens. VYNE will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the financial results and provide a corporate update. Conference Call Details: Wednesday, November 10th @ 8:30am Eastern Time Toll Free: 855-327-6837 International: 631-891-4304 Conference ID: 10017178 Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1512469&tp_key=ee68066700 DOWNLOAD: 2021 Q3 VYN201 Earnings_Presentation About VYNE Therapeutics Inc. VYNE’s mission is to improve…

Read More

VYNE Therapeutics to Present at the Cantor Fitzgerald Investment Conference

September, 20 2021

BRIDGEWATER, N.J., Sept. 20, 2021 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that David Domzalski, Chief Executive Officer, will present at the Cantor Fitzgerald Virtual Global Healthcare Conference, to take place September 27th – 30th. The presentation will take the form of a fireside chat, which will be archived here for 90 days. Management will also be available for 1-on-1 meetings with investors. Presentation details  Date:  September 28th Time:  4pm ET Webcast: https://wsw.com/webcast/cantor12/vyne/2115540 About VYNE Therapeutics Inc. VYNE’s mission is to improve the lives of patients by developing proprietary, innovative, and differentiated therapies…

Read More

VYNE Therapeutics to Present at the H.C. Wainwright Annual Investment Conference

September, 08 2021

BRIDGEWATER, N.J., Sept. 08, 2021 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that David Domzalski, Chief Executive Officer, will present at the H.C. Wainwright 23rd Annual Global Investment Conference to be held virtually from September 13th – 15th. The presentation will take the form of a fireside chat, which will be available on demand here beginning September 13th at 7:00 AM (ET) and archived for 90 days. Management will also be available for 1-on-1 meetings with investors. Date: September 13 Time: On Demand, beginning at 7:00 AM (ET) Webcast: VYNE Fireside Chat For…

Read More